Literature DB >> 12643142

Diagnosis of CAD in patients with diabetes: who to evaluate.

Lawrence H Young1, Powell Jose, Deborah Chyun.   

Abstract

Effective diagnosis and treatment of coronary artery disease (CAD) are key to the management of patients with diabetes. Although the use of specialized cardiac testing for CAD screening in asymptomatic patients varies widely and is the source of current controversy, evidence is emerging on the prevalence and predictors of asymptomatic ischemia in diabetic patients. Accurate diagnosis and risk stratification are essential in symptomatic patients with known or suspected CAD. Noninvasive cardiac testing has an important role in these patients, although evaluation for revascularization with cardiac catheterization is warranted in high-risk circumstances. This article reviews recent information that may help guide the clinician in the appropriate use of cardiac testing in diabetic patients.

Entities:  

Mesh:

Year:  2003        PMID: 12643142     DOI: 10.1007/s11892-003-0048-3

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  50 in total

Review 1.  Screening for asymptomatic coronary artery disease in diabetes.

Authors:  R W Nesto
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

2.  Investigation of coronary artery disease in diabetes: is screening of asymptomatic patients necessary?

Authors:  J W Sayer; A D Timmis
Journal:  Heart       Date:  1997-12       Impact factor: 5.994

3.  Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in noninsulin-dependent diabetes mellitus. Milan Study on Atherosclerosis and Diabetes (MiSAD) Group.

Authors: 
Journal:  Am J Cardiol       Date:  1997-01-15       Impact factor: 2.778

4.  Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography.

Authors:  G Vanzetto; S Halimi; T Hammoud; D Fagret; P Y Benhamou; D Cordonnier; B Denis; J Machecourt
Journal:  Diabetes Care       Date:  1999-01       Impact factor: 19.112

5.  Cardiac outcomes after myocardial infarction in elderly patients with diabetes mellitus.

Authors:  Deborah Chyun; Viola Vaccarino; Jaime Murillo; Lawrence H Young; Harlan M Krumholz
Journal:  Am J Crit Care       Date:  2002-11       Impact factor: 2.228

6.  A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women.

Authors:  J E Manson; G A Colditz; M J Stampfer; W C Willett; A S Krolewski; B Rosner; R A Arky; F E Speizer; C H Hennekens
Journal:  Arch Intern Med       Date:  1991-06

7.  Silent myocardial ischemia in patients with diabetes: who to screen.

Authors:  B Janand-Delenne; B Savin; G Habib; M Bory; P Vague; V Lassmann-Vague
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

8.  Assessment of asymptomatic coronary artery disease in apparently uncomplicated type 2 diabetic patients: a role for lipoprotein(a) and apolipoprotein(a) polymorphism.

Authors:  Carmine Gazzaruso; Adriana Garzaniti; Stefano Giordanetti; Colomba Falcone; Emanuela De Amici; Diego Geroldi; Pietro Fratino
Journal:  Diabetes Care       Date:  2002-08       Impact factor: 19.112

9.  Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.

Authors:  G I Barbash; H D White; M Modan; F Van de Werf
Journal:  J Am Coll Cardiol       Date:  1993-09       Impact factor: 24.094

10.  Comparison of prognosis of acute myocardial infarction in insulin-treated diabetic women versus men. The SPRINT Study Group.

Authors:  C Milo; H Reicher-Reiss; U Goldbourt; V Boyko; S Behar
Journal:  Am J Cardiol       Date:  1994-12-15       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.